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ABSTRACT 
The structures of biomolecules and their interactions dictate their functions. In this thesis, five 
papers are presented to illustrate how the dynamics of biomolecules can be investigated and 
derivation of desired thermodynamic quantities obtained by utilising a diverse range of 
computational techniques, from simulations utilising classical mechanical descriptions to 
calculations employing quantum mechanical descriptions. 
Classical simulation, referring to molecular dynamics simulation with atomistic force fields, 
has been used in every paper in this thesis. In Paper I, classical simulation and homology 
modelling are used to investigate the dynamics of a protein as well as that of its homologues, 
which have a missing region. Protein purification and production of these homologues was 
also attempted.  
When state transitions like protonation and tautomerisation equilibria are central to the query, 
we employed lambda-dynamics, an extension to conventional simulation that can describe 
transitions between states by including coupling parameter lambda in the dynamics. In Papers 
II and III, protonation and tautomerisation equilibria respectively are central to the query.  
In Paper II, lambda-dynamics and multiple pH regime are both used to calculate the pK shifts 
of cytidine in triplex nucleic acid environments. In some of the triplex nucleic acid systems, 
sugar modification LNA is present. The force field parameters of LNA have been updated to 
provider better descriptions for pK calculations. In Paper III, lambda-dynamics is used to 
describe tautomerisation equilibrium between two tautomers of pseudoisocytidine in single-
stranded and triple-stranded nucleic acids in order to observe how the equilibrium shifts in 
different environments. In vitro binding assay is used to corroborate the computational 
results. 
When greater accuracy for certain properties like electrostatics or energetics is required, we 
employed quantum mechanical calculations as well as hybrid methods which combine 
classical and quantum mechanical descriptions. In Paper IV, QM and QM/MM calculations 
were performed to calculate the energetic difference between two tautomers in the ribosome. 
In Paper V, protein-specific polarised charge, a charge update scheme that updates the atomic 
charges with QM and Poisson-Boltzmann calculations during classical simulation, is used for 
better electrostatics description of a peptide. 
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1 INTRODUCTION 
An important principle tenet of structural biology is that structure leads to function. The core 
questions that comes up yet and again in this thesis, or indeed in structural biology at large, is 
about structure: how a residue substitution will affect the structure, how different interactions 
will change the structure, how the structure explains the experimental observation, and so on.  
In this thesis, a diverse set of computational tools has been utilised to answer these questions. 
Classical simulations, referring to simulating the system with classical mechanics, are used; 
but if the question requires greater level of accuracy, ab initio calculations, which describe 
the system with quantum mechanics, are employed, albeit at greater computational cost. As 
the title of this thesis suggests, not only these two ends of the spectrum are used, but also 
some others in-between. 
The aim of this thesis is to understand biomolecules from the perspective of their structures 
— which give rise to biophysical properties such as state transitions, free energy, interactions 
with other molecules, among others — with various computational techniques.  
This thesis frame has been structured to begin from more general concepts and progress to 
increasingly specialised ones:  
The biomolecular systems are briefly introduced in Section 2. The common starting point of a 
computational biophysics investigation, the three-dimensional structure, is discussed in 
Section 3; followed by several biophysical properties of focus, in Section 4. Different levels 
of molecular descriptions are described in Section 5, then the various computational 
techniques used to sample the phase space and to derive the quantities of interest in Section 6. 
Finally, summaries of the papers, conclusions, and future outlook are presented in Section 7.  
In addition, the layman summary is provided in Section 8. The author strongly believes in the 
importance of effective communications of scientific ideas to the lay public, and hopes that 
this summary makes this thesis more accessible to the general audience.  
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2 BIOMOLECULAR SYSTEMS 
At the molecular level, life is composed of many types of molecules, such as proteins, nucleic 
acids, lipids, carbohydrates, small molecules, and others. While lipids and carbohydrates 
often form repeating assemblies, proteins and nucleic acids are long polymers that fold to 
specific shapes depending on their monomeric composition and the environment.  
Proteins are composed of diverse combinations of over 20 different amino acids with varying 
biochemical properties: charged, hydrophobic, acidic, basic, and others.  Consequently, 
proteins, with their vast array of structures, perform many functions: catalysis, ion transport, 
receptor, messenger, among others.  
 
Figure 1. MPER peptide adsorbed to a micelle. 
An example of protein is MPER (membrane proximal ectodomain region) peptide,
1
 a short 
peptide fragment of HIV envelope protein (Figure 1). The envelope protein plays a major role 
in HIV cell infection process by facilitating membrane fusion.
2
 This is the protein of interest 
in Paper V. 
Compared to proteins, nucleic acids are composed of fewer letters (residues) with less diverse 
biochemistry. The two types of nucleic acids, DNA and RNA, differ in the sugar moiety by a 
2’ hydroxyl group, which is present in RNA and absent in DNA. DNA, typically forming 
double-stranded helix, mainly functions as storage of genetic information. RNA, typically 
single-stranded with more diverse secondary structures, has diverse functions, for example: 
catalyst function in ribozyme, messenger in messenger RNA (mRNA) and transfer RNA 
(tRNA), scaffold and catalyst in ribosomal RNA.  
The ribosome is a protein-producing machinery which itself is an assembly of proteins and 
RNA. The protein-producing process is called translation, during which genetic information 
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from the mRNA is “translated” by the tRNA to polypeptides, which may undergo further 
port-translational processing to yield the functional proteins. The information in mRNA is 
read one nucleotide triplet (termed codon) at a time by the tRNA, which has the triplet with 
complementary sequence to the codon (termed anticodon). The process of mRNA reading 
during elongation stage of translation happens in specific site in the ribosome called the 
decoding region in the aminoacyl site. The ribosome has three sites for tRNA: aminoacyl site 
(A-site) where it holds the incoming tRNA with the correct anticodon binding to the mRNA 
codon; peptidyl site (P-site) where it holds tRNA with growing polypeptide; exit site (E-site) 
where it holds the exiting tRNA without its amino acid charge.  
 
Figure 2. Subset of the ribosomal decoding region from X-ray crystal structure.  
tRNA ASL refers to the tRNA anticodon stem loop. Inset shows cmo
5
U:G basepair in 
Watson-Crick geometry 
The ribosomal scaffold ensures the fidelity of translation by making non-complementary 
tRNA-mRNA interactions unfavourable. This selection is tighter for the first and second 
codon positions, while some mismatches are allowed for the third position.
3-4
 One example is 
G:U mismatch which typically form the wobble configuration with two hydrogen bonds, 
instead of three in a complementary Watson-Crick G:C match. In Paper IV, we are interested 
in a particular interaction in the third position, where a modified U:G basepair is observed to 
have Watson-Crick geometry in the X-ray crystal structure (Figure 2).  
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Figure 3. The structures of human eRF1 (X-ray) and vRF1s (homology models). 
Besides coding for the amino acids, the codons also signal the start and the end of translation. 
Codons that signal for termination of translation are called stop codons, and instead of being 
read by tRNA, a protein factor recognises the stop codon instead. In eukaryotes, this protein 
is called eukaryotic release factor 1 (eRF1).
5
 eRF1 and its homologues found in giant viruses, 
are the subject of interest in Paper I (Figure 3). 
Although the double helix is the typical conformation of DNA, in particular circumstances 
there is enough steric space to accommodate a third strand to form a triplex. When a double 
helix with Watson-Crick basepairing is formed between a homopyrimidine strand and a 
homopyrimidine strand, a third homopyrimidine strand can bind at the major groove of the 
double helix via Hoogsteen basepairing to from a parallel triple helix (Figure 4). With 
canonical DNA bases, the possible base triads are C
+G–C and TA–T (‘–’ refers to Watson-
Crick and ‘’ to Hoogsteen base pair), where cytidine in the third strand needs to be 
protonated to form Hoogsteen hydrogen bond. The parallel triple helix system is discussed in 
Papers II and III. When discussing a triple helical nucleic acids system, it is common to refer 
to the third strand as the triplex-forming oligonucleotides (TFO). The conformation of the 
duplex bound to the TFO is known to be close to that of A-form geometry.
6-8
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Figure 4. Parallel triple helix and base triads, shown with Watson-Crick (WC) and 
Hoogsteen (HG) hydrogen bonding. 
 Although there are only 4 basic letters for DNA and RNA that are used in the genetic code, 
there are various modifications, natural and artificial, of the bases that play important roles in 
various translational and epigenetical processes. The tRNA, for example, contains many 
modifications that modulate its codon-reading activities.
9-10
 A natural DNA modification of 
cytosine, 5-methylation,
11
 is mentioned in Papers II and III. A natural RNA base modification 
of uridine at the first anticodon position, 5-oxyacetic acid uridine (cmo
5
U) (Figure 5), is 
mentioned in Paper IV. With this modification at first anticodon position, it can accept all 
four bases.
12
 There are also various artificial modified bases such as pseudoisocytosine  
(
Ψ
C),
13
 (Figure 5) derived from natural modified base pseudouridine, that is incorporated in a 
TFO to form a more stable triplex nucleic acids, mentioned in  Paper III.  
 10 
 
Figure 5. Chemical structures of two modified bases, shown with the corresponding 
canonical bases. (A) Cytidine and pseudoisocytidine (B) Uridine and 5-oxyacetic acid uridine 
An artificial sugar modification, locked nucleic acid
14-15
 (LNA, see Figure 6), is also 
mentioned in Papers II and III, where it is also used in TFO to improve duplex binding to 
form the triplex.
16
 With LNA modification, the sugar pucker is fixed to C3’-endo (also called 
North conformation), which is prevalent in A-form geometry.
14
  
 
Figure 6. Chemical structures of LNA and DNA. 
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3 THREE-DIMENSIONAL STRUCTURE 
The three-dimensional coordinates of atoms of the biomolecule of interest is the starting point 
for a computational biophysics investigation. These coordinates are by large resolved 
experimentally (while some are modelled computationally) and are typically deposited in 
public repositories such as the Protein Data Bank (PDB) (rcsb.org)
17
 and the Electron 
Microscopy Data Bank (EMDB) (emdatabank.org).
18
 The three main experimental 
techniques to resolve the three-dimensional structure of a biomolecule are X-ray 
crystallography, nuclear magnetic resonance (NMR) spectroscopy, and cryo-electron 
microscopy (cryo-EM). The sample preparation stage needed for these techniques is also 
discussed, with special focus on protein production and purification. 
3.1 X-RAY CRYSTALLOGRAPHY 
X-ray crystallography makes use of the diffraction patterns obtained by beaming high-
intensity X-ray at a crystallised biomolecule (see Ref. 
19
 for a short review). Diffraction 
occurs due to the molecules oriented in repeating manner. Back-calculation of the diffraction 
patterns can yield back the atomic coordinates of the molecule.  
X-ray crystallography typically cannot resolve hydrogen atoms because of their low electron 
density. Also, flexible parts of the molecule often cannot be resolved since they may end up 
in slightly different positions in the crystal and do not give rise to good diffraction. 
Crystallisation condition is also highly individualised for each protein and conditions at 
which a protein will crystallise well are often determined by trial and error, i.e. by screening 
in thousands of conditions. Another problem is that due to close contact of the molecules in a 
crystal, the environment may be vastly different compared to the molecule in solution, which 
is the typical physiological environment of a soluble protein.  
3.2 NMR SPECTROSCOPY 
Structural determination by solution NMR spectroscopy
20
 uses mainly measured nuclear 
Overhauser effect (NOE) nucleus-nucleus distances, which are used to restrain the initial 
model of the molecule in a narrow scope of conformations.
21
 The coordinates are therefore 
typically deposited as an ensemble of structures that are lowest in energy of have least 
restraint violations. Also, since the atomistic model is already pre-built, an NMR structure 
would not have missing atoms like an X-ray structure might. Other NMR measurements, 
such as residual dipolar coupling, can also be inputted as additional restraints in structure 
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calculation. The NMR data processing relies on computational tools to interpret the data and 
evaluate the biomolecular structure.
22
  
Since the sample is in solution, the biomolecule can also be measured in its close-to-native 
environment, although solid state NMR spectroscopy for biomolecules is now an active area 
of research. However, a biomolecule might only be highly soluble in certain conditions that 
might not be close to its native physiological environment, since NMR spectroscopy requires 
quite high concentration of the biomolecule to yield good signal-to-noise ratio. Another 
limitation is that solution NMR spectroscopy can only be typically used up to certain 
biomolecular size as the signal will degrade faster the bigger the size. Development of NMR 
pulse sequences to increase the size limit, for instance that used in transverse-relaxation 
optimised spectroscopy (TROSY),
23
 is an ongoing effort. 
3.3 CRYO-ELECTRON MICROSCOPY 
In cryo-electron microscopy, the biomolecule is suspended in thin layer of vitreous ice, and 
electron micrographs are taken. Image sorting algorithm is then used to sort the images of the 
molecule in different orientations and to construct the three-dimensional model.  Vitreous ice 
ensures that the molecule is in close to solution environment. Cryo-EM have been used for 
large particles such as the ribosome,
24-27
 that may be more challenging to obtain in good yield 
or to crystallise for X-ray measurement. The purity requirement is also less strict than that of 
X-ray crystallography since contaminants can be graphically sorted out. Cryo-EM has been 
on the rise in the recent years, as it is approaching atomic resolution.
28
 
3.4 SAMPLE PREPARATION 
In order to perform these measurements, the biomolecule sample needs first to be prepared. 
For small peptides and oligonucleotides, chemical synthesis may be used. For proteins, they 
may be purified directly from the source, but recombinant technology may be used to 
increase the yield. For example, in Paper I, we cloned the gene of interest in E. coli and 
cultured it to overexpress the protein of interest. Other hosts such as yeast, insect cells, or 
human cells might be used as well, depending on the suitability with the protein. For 
example, E. coli may not be appropriate for proteins for which post-translational 
modifications are important for the investigation.  
Let us consider a typical workflow of recombinant protein production and purification.
29
 
First, the gene should be cloned in an appropriate vector and sequence-verified. The host is 
then transfected, cultured, and induced at appropriate times to produce the protein. The cells 
are harvested and centrifuged, then resuspended in buffer and agitated to break the cell 
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membranes, then centrifuged again. For soluble proteins, the supernatant is subjected to 
purification stage. 
For protein, it is a common practice to include an affinity tag covalently bound to the 
recombinant protein. Proteins containing hexahistidine tag,
30
 for instance, can be purified in 
the first stage with immobilised metal affinity chromatography (IMAC) with Ni
2+
 or Co
2+
 ion 
column. More chromatographic techniques typically follow, depending on the criteria of 
purity. Size-exclusion chromatography (SEC) is often a choice due to its versatility. Other 
columns, for instance, ion-exchange chromatography (IEX), may need calibration trials to 
determine the optimal ionic strength gradient. 
Protein production and purification is often challenging, because although standardised 
workflow exists, it needs to be customised and optimised specific to the protein of interest. 
Here are some considerations other than those already mentioned: sequence construct – 
beginning or ending amino acids may affect the overall solubility and expression of the 
protein; difficulty level of maintaining host culture; buffer composition and pH.    
3.5 COMPUTATIONALLY-SOURCED MODELS  
3.5.1 From homology modelling 
As the PDB contains many deposited structures, they can be used as templates to resolve the 
structure of homologous sequence. For example, certain sequence might always form an α-
helix, so the structure of a new (never structurally resolved) protein containing this sequence 
can be predicted to be an α-helix. Homology modelling has low computational cost, but the 
validation stage is challenging. Many homology modelling software suites and servers are 
available, such as MODELLER,
31-34
 SWISS-MODEL,
35-38
 and I-TASSER.
39-41
 
3.5.2 From de novo protein folding 
In de novo protein folding,
42
 one starts from linear conformation of the molecule, and let the 
force field and molecular dynamics simulation or other computational techniques 'fold' it into 
lower energy conformation, which should ideally correspond to the experimental structure. 
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4 BIOPHYSICAL PROPERTIES 
The aim of a computational biophysics investigation is often to obtain biophysical properties, 
qualitatively or quantitatively, for comparison with experiments, or to gain insights into 
processes which are experimentally intractable. In this section three processes of interest – 
binding, protonation, and tautomerisation – are discussed. 
4.1 BINDING AND ADSORPTION 
Binding interactions are specific interactions between molecules, often designated as a ligand 
and a target.  Fischer's lock-and-key model
43
 is a useful metaphor to illustrate the specificity 
criterion of a binding event. A target molecule has specific moieties with specific 
orientations, and the ligand molecule has to match these in order to bind. A protein-water 
interaction, for example, is not binding because it is non-specific, though there are exceptions 
where a water molecule acts as a ligand, always keeping the same orientation — we know 
this as there are crystal structures with resolved water molecules.
44
 
In many cases, we are interested intermolecular interactions that drive binding as they are 
intricately linked to structure and function. For example, it is mentioned above that the 
ribosome performs the translation process (function) by accommodating various molecules 
(binding) at different stages. The ribosome architecture itself (structure) is important such that 
the molecules can be accommodated. 
In triplex nucleic acids, we are mostly interested in the binding interactions of TFO with the 
double-stranded target via Hoogsteen hydrogen bond. Binding interactions of TFO with the 
target duplex have prospective applications in antigene therapy, where sequence-specific 
TFO may be designed to block certain region of the double-stranded DNA target gene to 
prevent its transcription.  One problem of TFOs containing cytosine residue is that it needs to 
be protonated to form two hydrogen bonds of Hoogsteen. This limits the TFO application as 
the acidic environment becomes a pre-requisite. The use of pseudoisocytidine to substitute for 
cytidine is one strategy to circumvent this limitation. 
An experimental technique, called electrophoretic mobility shift assay (EMSA), can be used 
to assess binding of biomolecules in vitro. In the case of duplex-TFO binding, first the target 
duplex is radiolabelled, and TFO is added. After allowing time for hybridisation, the sample 
is loaded in the polyacrylamide electrophoresis gel with non-denaturing condition. 
Electrophoresis is performed and the gel is then visualised. If triplex is formed, an upward 
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band shift would occur because the triplex would have greater molecular weight than that of 
the duplex (Figure 7). 
 
Figure 7. An electrophoretic mobility shift assay (EMSA) gel of TFO binding experiment. 
DS is duplex; TS is triplex.   
Adsorption, in contrast to binding, is non-specific. We have used the term loosely in Paper V 
to describe the non-specific interactions of a peptide and a micelle and quantify it simply by 
measuring the inter- centre-of-mass distance.  
4.2 PROTONATION  
Protonation/deprotonation equilibrium is ubiquitous since it involves the universal solvent 
water. The term pKa, the decimal cologarithm of acid dissociation constant Ka, is a measure of 
how much H
+
 dissociates from an acid. The more general notation pK shall be used in this 
thesis. Let us consider the protonation/deprotonation equilibrium of cytosine: 
 
The equilibrium constant K and cologarithm  pK are:  
𝐾 =
[cyt][H3O
+]
[cytH+]
 and p𝐾 = − log
[cyt][H3O
+]
[cytH+]
 
The pK value of the cytosine is 4.4.
45
  Since the equation can be rearranged to include pH, i.e. 
p𝐾 − pH = log
[cyt]
[cytH+]
, we may also statistically interpret pK = 4.4 as the pH value for which 
the populations of deprotonated and protonated states of cytosine are equal. 
The free energy of deprotonation can be expressed in terms of pK:  
Δ𝐺deprot= ln(10) 𝑘𝐵𝑇(p𝐾 − pH) 
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4.3 TAUTOMERISATION 
Tautomers are readily interconvertible isomers,
46
 where a common form is prototropic 
tautomers, where the tautomers differ just by the location of a proton. Investigations of 
tautomerisation, particularly that of nucleic acids, are often experimentally challenging due to 
the fast interconversion, structural similarity of the tautomers, and low abundance of minor 
tautomers.
47
 
 
Figure 8. Tautomers of (A) pseudoisocytidine (
Ψ
C) and (B) uridine. 
In this thesis, the prototropic tautomers of pseudoisocytidine (
Ψ
C), the aforementioned 
artificial base, which are two main amino tautomers, 
Ψ
C(H1) and 
Ψ
C(H3) will be mentioned; 
as well as those of uridine, which are one main keto tautomer and two rarer 2- and 4-enol 
tautomers (Figure 8).  
The associated thermodynamic quantities for A⇋B tautomerisation are the equilibrium 
constant 𝐾A⇋B =
[B]
[A]
 and the free energy of tautomerisation Δ𝐺A⇋B = 𝑘B𝑇ln 𝐾A⇋B. 
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5 MOLECULAR DESCRIPTIONS 
Now that we have the three-dimensional coordinates of the atoms, we have to describe the 
biomolecule and its intra- and inter-particle interactions. We can divide molecular 
descriptions in two broad categories: (1) with classical mechanics, also known as molecular 
mechanical (MM) description; and (2) with ab initio or quantum mechanical (QM) 
description. There also exist hybrid methods which mix the two, or use both descriptions for 
different subsets of the system (the latter is also called multiscale modelling).    
5.1 CLASSICAL MOLECULAR MECHANICS DESCRIPTIONS 
The biomolecule can be represented as rigid beads with various inter-bead interactions 
described by classical mechanics. If a bead represents an atom each, the description is said to 
be atomistic or all-atom. To expedite calculations, a bead may also represent a group of atoms 
– this is termed coarse-grained description. In this thesis, we shall focus on the atomistic level 
of granularity. 
The model describing the interatomic interactions is called the force field. There are various 
kinds of force fields, which may be designed for different purposes, or specifically for a 
specific class of molecules. Examples of force fields for biomolecules include OPLS,
48
 
GROMOS,
49-52
 AMBER,
53-55
 and CHARMM;
56-64
 the latter two of which are used in this 
thesis. 
The force field is formulated as a potential energy function with empirical parameters 
describing the atoms and their interactions. The empirical parameters are supplied by 
experimental values and quantum mechanical ab initio calculations. Let us consider an all-
atom potential energy function:    
𝑈(?⃗? ) = ∑ 𝐾𝑏(𝑏 − 𝑏0)
2
bonds
+ ∑ 𝐾𝜃(𝜃 − 𝜃0)
2
angles
+ ∑ 𝐾𝜑(1 + cos(𝑛𝜑 − 𝛿))
dihedrals
+ ∑ 𝐾𝜔(𝜔 − 𝜔0)
2
impropers
+ ∑ {𝜀𝑖𝑗
min [(
𝑅𝑖𝑗
min
𝑟𝑖𝑗
)
12
− 2(
𝑅𝑖𝑗
min
𝑟𝑖𝑗
)
6
] +
𝑞𝑖𝑞𝑗
4𝜋𝜀0𝜀𝑟𝑖𝑗
}
non-bonded pairs
 
This is the potential energy function used by CHARMM
56
 (omitting some correction terms 
for clarity). The terms comprise bonded and non-bonded terms. The three bonded terms –
bonds, angles, and impropers – are described by harmonic functions with their respective 
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force constants 𝐾𝑏, 𝐾𝜃, 𝐾𝜔 and equilibrium bond length, angle, improper values 𝑏0, 𝜃0, 𝜔0. 
The bonded term, dihedrals, is described by a cosine function in which  𝐾𝜑 is the amplitude; 
𝑛, periodicity; 𝛿, phase angle. Non-bonded term consists of 6-12 Lennard-Jones potential, 
describing van der Waals interactions, and Coulomb potential, describing electrostatic 
interactions. 𝑖𝑗 is the indices of the atom pair in consideration; 𝜀𝑖𝑗
min, well depth; 𝑟𝑖𝑗, 
interatomic distance; 𝑅𝑖𝑗
min, the interatomic distance of minimal potential energy; 𝑞𝑖, point 
charge of atom 𝑖; 𝜀0, permittivity of vacuum; 𝜀, permittivity relative to vacuum.  
It is apparent in this formulation, the force field cannot account for certain chemical 
phenomena, such as polarisation, quantum effects, and chemical reactions where bonds are 
formed and broken. 
5.2 AB INITIO DESCRIPTIONS 
While we can compute the potential energy of the system with empirical parameters with 
force fields, ab initio calculations compute the energy of the system from first principles – 
molecular orbital theory in quantum mechanics – without empirical inputs (see reference 
textbook 
65
). 
In molecular orbital theory, the energy of the system can be computed by solving the time-
independent electronic Schrödinger equation, ℋΨ = 𝐸Ψ, where evaluation of the 
Hamiltonian operator ℋ on the wavefunction Ψ yields back the wavefunction multiplied by 
the electronic energy 𝐸.  
The level of theory refers to the method of approximation used to solve the Schrödinger 
equation, since it cannot be solved exactly in many-electron system. The Hartree-Fock 
(notation: HF) method is a fundamental approximation which higher levels of theory (‘post-
HF’) improve upon. One important assumption in HF method is the Born-Oppenheimer 
approximation where the nuclei are considered fixed and decoupled from electronic motions. 
Employing the variation theorem, which states that a better approximation to the 
wavefunction leads to a lower energy, HF method includes an iteration procedure to produce 
lower energy. For this reason, HF method is also known as self-consistent field (SCF) 
method.   
HF method also assumes that each electron interacts with an average charge distribution due 
to other electrons (mean field approximation), so it does not fully account for electron 
correlation. Møller–Plesset perturbation theory is a post-HF method that adds the electron 
correlation correction terms to the HF energy. It has been mentioned that QM calculations are 
  19 
used to parameterise force field. Such calculations are typically done at second-order Møller–
Plesset (notation: MP2) level of theory for geometry optimisations. We will also encounter 
B3LYP, a hybrid functional method combining HF and density functional theory (DFT), 
which also provides improvement over HF result.   
The basis set is the set of atomic functions used to construct the wavefunction. Although 
Slater-type orbitals are better representations, in practice, an approximation of these orbitals 
by linear combination of Gaussian-type functions are used, for ease of computation. The size 
of basis set to be used in a calculation depends on the system and accuracy-speed trade-off 
consideration. A minimal basis set contains only the functions representing all the filled 
orbitals. For example, in STO-3G minimal basis set, 3 Gaussian functions are used to 
represent a Slater-type orbital. In larger basis sets, additional functions are used represent 
orbital diffusion or contraction in response to the molecular environment. For example, in 3-
21G basis set, 3 Gaussian functions are used to describe core orbitals, 3 Gaussian functions 
are also used to describe the valence orbitals – of which 2 is for contraction, 1 is for diffusion. 
These so-called split valence basis sets are most used in this thesis. Even larger basis sets may 
also include polarisation functions (*) and additional diffuse functions (+). A single * or  + 
notation indicates that the functions are added for heavy atoms, and a double ** or ++ 
notation indicates that the functions are added for all atoms. 
In this thesis, we will encounter notations of ab initio calculations specifying the level of 
theory and the basis set. Let us consider the following notation: MP2/6-31++G**. The 
notation specifies that the energy is calculated at MP2 level of theory with basis set 6-
31++G**, which is a split valence basis set where 6 Gaussian functions are used to represent 
a Slater-type orbital (for the valence orbitals, 3 are used for contractions and 1 for diffusion) 
and polarisation and additional diffuse functions are included for all atoms.  
If the notation contains two levels of theory and basis sets, for example: MP2/6-
31++G**//MP2/3-21+G**, this signifies that geometry optimisation has been done at MP2/3-
21+G**, and the energy of the optimised structure is evaluated at MP2/6-31++G**. This is a 
common practice whereby the more expensive geometry optimisation calculation is done 
with smaller basis set and the energy evaluation with a larger one, to lower computational 
cost. 
To include bulk solvent effects, a common strategy is to use polarisable continuum model 
(PCM).
66
 In PCM method, the solute is represented by point charges on the surface of a 
cavity surrounded by a polarisable medium. The charges polarise the medium, which creates 
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a reaction field, which polarises the solute back until equilibrium is reached.  The solvation 
free energy calculated by PCM comprises electrostatic, dispersion-repulsion, and cavity 
terms. 
5.3 HYBRID DESCRIPTIONS 
5.3.1 QM/MM 
Since QM calculation is computationally costly, it is only practical for small-molecule 
systems. QM/MM hybrid method represents a part of the system with QM, for which 
precision is needed, and the rest of the system with MM.  
The system partitioning gives rise to problems associated with the interface between the MM 
and QM regions. Three such problems are highlighted and the available strategies briefly 
described.
67
 
First, how to add the energies. In subtractive scheme, the energy of entire system is calculated 
at MM level, energy of QM region is evaluated at QM level, then energy of QM region 
evaluated at MM level is subtracted from the total to correct for the link atoms. In additive 
scheme, MM calculation is only done for MM region, energy of QM region is evaluated at 
QM level, then energy of coupling between the two systems is added.  
Second, how to treat electrostatics. In mechanical embedding, the electrostatics of the QM 
region is treated the same as that of MM region. In electrostatic embedding, the rigid MM 
point charges are included in the QM Hamiltonian. In polarised embedding, flexible MM 
point charges are used to allow for polarisation of MM region. 
Third, how to cut covalent bond. Often, the QM/MM boundary would cut through a covalent 
bond. A common strategy is to add a monovalent link atom, typically hydrogen, to 
electronically saturate the QM region. The link atom itself introduces other problems such as 
additional artificial degrees of freedom, and chemical difference between the link atom and 
the original group. Boundary-atom scheme uses an atom that is included in both QM and 
MM regions. Localised-orbital scheme uses hybrid orbitals to cap the QM region instead.     
The Q-Chem/CHARMM interface
68
 used in this thesis (Paper IV) uses additive scheme, 
electrostatic embedding, and hydrogen link atoms.  
5.3.2 Polarised protein-specific charge 
Polarised protein-specific charge (PPC) scheme
69
 is an attempt to describe protein 
electrostatics better, since in standard force fields, polarisation is not fully accounted for. The 
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scheme updates the atomic charges as the environment changes in MD simulation run, thus 
taking polarisation implicitly into account. The charge update itself involves fragmenting the 
molecule, QM calculation at B3LYP/6-31G* level, charge fitting, and linearised Poisson-
Boltzmann equation — this is iterated until solvation energy and the charges converge. There 
also exists a variant of PPC scheme, adaptive hydrogen bond charge (AHBC),
70
 where the 
charge update is only applied to residues involved in hydrogen bonds to expedite 
computation.  
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6 SIMULATION TECHNIQUES 
Now that we have the molecular representations and ways to account for the interactions, we 
need to sample the phase space, which contain every possible momentum and position of 
every particle in the system. We shall consider first conventional molecular dynamics, used in 
every paper in this thesis, then an extension called λ-dynamics that is able to describe 
transitions between states, for example those between tautomeric forms or protonation states. 
Next we shall consider techniques to obtain specific thermodynamics properties of interest: 
multiple pH regime to obtain pK and methods to obtain free energy and PMF.  
6.1 MOLECULAR DYNAMICS 
Molecular dynamics (MD) simulation propagates the coordinates of the molecules in function 
of time by numerically integrating Newton’s equation of motion, which in one dimension is: 
𝑑2𝑥𝑖
𝑑𝑡2
=
𝐹𝑥𝑖
𝑚𝑖
 
Where it describes the motion of a particle 𝑖 of mass 𝑚𝑖 along coordinate 𝑥𝑖 with force 𝐹𝑥𝑖 
acting on the particle in direction 𝑥𝑖. The forces, being the negative partial derivative of the 
potential energy, can be obtained from the force field.  
Since motions of particles are coupled together, the equations of motion cannot be solved 
analytically and is solved numerically in discrete time steps. The integration time step is 
chosen to be small enough to conserve momenta of molecular motion. In the case of 
biomolecules, time step of 2 fs with SHAKE constraints
71
 on bonds involving hydrogen is 
typically sufficient. 
MD simulation thus samples positions and velocities of the particles in the system and 
produces a time trajectory thereof, from which the time average of the desired observables 
can be obtained. Assuming ergodicity, the time average is regarded as equal to the ensemble 
average, from which thermodynamic properties can be derived with statistical mechanics. 
To apply statistical mechanics, MD simulations have to be performed in the appropriate 
thermodynamics ensembles, which are typically constant NVE (microcanonical), constant 
NVT (canonical), and constant NPT (isothermal-isobaric) [N: number of particles; V: volume; 
E: internal energy; P: pressure].  
To maintain temperature, simple velocity scaling
72
 can be employed, since the temperature is 
related to the average kinetic energy. Alternatively, Berendsen thermostat
73
 can be used, in 
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which the system is coupled to an external heat bath. Nosé-Hoover thermostat
74-75
 is a more 
rigorous method where the heat bath is part of the system, represented as additional degree of 
freedom with fictitious mass, which controls the energy flow between the system and the heat 
bath. With Andersen thermostat,
76
 a particle is chosen at random at intervals and its velocity 
randomly reassigned from Maxwell-Boltzmann distribution. With Langevin thermostat, 
frictional drag and random collisions are introduced and adjusted to achieve the desired 
temperature.
65
 To maintain pressure, barostats analogous to the above thermostats may be 
employed where volume of the simulation cell is scaled. Berendsen barostat
73
 analogously 
couple the system to a ‘pressure bath’ like the thermostat. Andersen barostat76 is analogous to 
Nosé-Hoover thermostat where external variable acts as a piston to maintain pressure.  
Periodic boundary conditions (PBC) are often used in order to eliminate boundary effects. 
Here, the simulation box is replicated in all directions. A particle that leaves the box will thus 
be replaced by its image entering from the opposite side. In some cases, PBC may not be an 
appropriate choice. For instance, in Paper IV we simulated a spherical region carved out of 
the ribosome, and PBC is not suitable for such inhomogenous system. We instead used 
deformable stochastic boundary potential
77-78
 to contain the system in a sphere. Here, the 
process of interest is kept in the centre, surrounded by Langevin stochastic heat bath to 
maintain equilibrium in the central region. 
To treat long-range forces, distance cutoff may be used, and as it introduces energy gap, 
smoothing functions are used to preserve energy continuity. Particle mesh Ewald method,
79
 
which more efficiently computes energy summation in Fourier space, may be used for 
electrostatics. 
6.2 LAMBDA-DYNAMICS 
One limitation of MD with molecular mechanics force field is that it cannot describe 
chemical transitions, where chemical bonds are broken and formed. Two examples of such 
chemical transition equilibria have been mentioned above: protonation/deprotonation and 
tautomerisation equilibria. 
λ-dynamics80-82 is an extension of molecular dynamics, where additional alchemical 
variable(s), typically denoted as λ, are included in the dynamics along with the atomic 
coordinates. λ indicates the distance along the alchemical transformation pathway. These 
transformations or transitions may occur between more than two forms or states – for 
example histidine has three tautomerisation/protonation states. They may also occur at more 
than one sites (multisite), for example a dipeptide containing two glutamic acids may need 
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descriptions of two protonation states for each titration site. In this thesis, we have used a 
particular formulation of λ-dynamics for CHARMM83 that has been shown to work for 
constant pH simulation of nucleic acids in explicit solvent.
84
 
Let us consider a λ-dynamics simulation where a two-state transition between state A and 
state B occurs at a single site. The two states A and B are described and propagated by 
continuous variables 𝜆A and 𝜆B respectively. The potential energy function is: 
𝑈tot(𝑋, {𝑥}, {𝜆})
= 𝑈env(𝑋) + 𝜆A[𝑈(𝑋, 𝑥A) − Δ𝐺A→B(model)] + 𝜆B[𝑈(𝑋, xB)] + 𝐹
bias(𝜆A)
+ 𝐹bias(𝜆B) 
We note that compared to a typical MD simulation, there are extra terms in the potential 
energy function. 𝑋 is the coordinates of environment atoms, 𝑥A and 𝑥B are coordinates of 
atoms corresponding to the states involved in the transition. 𝑈env(𝑋) is the potential energy of 
environment atoms not involved in the transition.  
The variable 𝜆𝑖 (𝑖 = A, B) scales the potential energy of the corresponding state with the 
constraints: 
0 ≤ 𝜆𝑖 ≤ 1 and 𝜆A + 𝜆B = 1 
Since λ is a continuous variable, it may linger in intermediate unphysical states, instead of at 
the end physical states which we are more interested in. To improve sampling at end states, a 
sampling bias term for each state is therefore introduced: 
𝐹bias(𝜆𝑖) = {
𝑘bias(𝜆𝑖 − 0.8)
2;  if 𝜆𝑖 < 0.8 
0 ;  otherwise
 
Here, 0.8 ≤ 𝜆𝑖 ≤ 1 is considered as a physical end state. 𝑘bias is the force constant of the 
biasing potential.  
Δ𝐺A→B(model) is the free energy difference between the two states in a model compound, 
which needs to be calculated beforehand. The free energy term is summed to the potential 
energy term of state A inside the scaling of 𝜆A, such that it is equally likely to be in state A as 
it is to be in state B. This value needs to be offset according to what is needed.  
For constant-pH simulation, let us consider deprotonated and protonated states A and A+. An 
additional pH-dependent term, ln(10) 𝑘𝐵𝑇(p𝐾model − pH), is included in 𝜆A scaling, such 
that: 
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𝑈tot(𝑋, {𝑥}, {𝜆}, pH)
= 𝑈env(𝑋) + 𝜆A[𝑈(𝑋, 𝑥A) − Δ𝐺A→A+(model)
+ ln(10) 𝑘𝐵𝑇(p𝐾model − pH)] + 𝜆A+[𝑈(𝑋, xA+)] + 𝐹
bias(𝜆A) + 𝐹
bias(𝜆A+) 
The term ln(10) 𝑘𝐵𝑇(p𝐾model − pH) adds offset when pH ≠ p𝐾model, where p𝐾model is 
experimentally measured pK of the model compound. . Without any offset, the equation 
would therefore describe a constant-pH simulation at pH = p𝐾model. 
In the case of deprotonation/protonation equilibrium, to further improve sampling, it also 
possible to run simultaneous simulations at different pHs, termed pH replica exchange.
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Since the replicas effectively just need to exchange Hamiltonians, this is a variant of 
Hamiltonian replica exchange.  
Finally, the simulations will yield the populations of each state. In the case of 
deprotonation/protonation equilibrium, pK of the system can be obtained by fitting to 
Henderson-Hasselbalch equation: 𝑆deprot =
1
1+10−𝑛(pH−p𝐾)
, where 𝑆deprot is the fraction of 
deprotonated state; 𝑛 is Hill coefficient and indicates degree of cooperativity between 
titratable groups.  
6.3 MULTIPLE PH REGIME 
Multiple pH regime
86
 is an approach that specifically aims to calculate pK by combining 
configuration sampling of MD with Poisson-Boltzmann equation for electrostatic calculation. 
Let us consider that we want to calculate pK of residue A in a certain environment. 
First, we sample A in this environment in two sets of ensembles, corresponding to 
deprotonated and protonated states, with MD simulation. From the two sets of configurations, 
we calculate the degree of deprotonation, and plot two titration curves. We then average the 
two titration curves and calculate the pK value. The electrostatic calculation is needed when 
we calculate the degree of protonation, since it is a function of change in electrostatic energy, 
which is in turn a function of intrinsic pK: 
p𝐾int = p𝐾mod + Δp𝐾Born + Δp𝐾cc 
The intrinsic pK, p𝐾int, is the pK value independent of ionisation properties of other groups in 
the system. p𝐾mod is the standard pK value for the model compound, which we need to 
supply. Δp𝐾Born is the pK shift due to desolvation, and Δp𝐾cc  is pK shift due to charge-
charge interactions. 
 26 
In Paper II, we have used a variant of this approach in which we use Poisson, instead of 
Poisson-Boltzmann, equation. Instead of having the ions implicit as ionic strength term, we 
include the ions explicitly as point charges and assume that they follow Boltzmann 
distribution, since they are sampled by MD simulation. This is because the environment of 
interest is the triple helix nucleic acids, where there are many negatively charged phosphates. 
Since Poisson-Boltzmann equation does not take into account the finite size of the mobile 
ions, the negative charges may introduce artefactually high mobile ion concentration around 
them, so the mobile ions are used explicitly as the source of electric potential.   
6.4 FREE ENERGY CALCULATION 
The free energy between two states 0 and 1, ∆𝐺(0 → 1), can be computed with: 
∆𝐺(0 → 1) = −𝑘𝐵𝑇 ln 〈exp [−
(𝑈1 − 𝑈0)
𝑘𝐵𝑇
]〉0 
Where 𝑘𝐵 is Boltzmann constant, 𝑇 is temperature, 𝑈 is the potential energy, 〈 〉𝑖 denotes 
ensemble average over state 𝑖. This equation is the basis of free energy perturbation (FEP) 
and is commonly called the exponential or Zwanzig equation.
87
 The free energy may also be 
expressed in different ways, for instance as an integral of 𝑈 over a parameter 𝜆 in 
thermodynamic integration method.
88
  
Bennett acceptance ratio and potential of mean force, which are used in this thesis, are 
described next. 
6.4.1 Bennett acceptance ratio 
In this thesis, we utilised an extension of FEP called Bennett acceptance ratio (BAR) 
method
89
 to compute the free energy. The BAR equation is: 
∆𝐺0→1 = 𝑘𝐵𝑇 ln (
〈𝑓(𝑈0 − 𝑈1 + 𝐶)〉1
〈𝑓(𝑈1 − 𝑈0 − 𝐶)〉0
) + 𝐶  
Where 𝑓(𝑥) is Fermi function, 𝑓(𝑥) =
1
1+exp (
𝑥
𝑘𝐵𝑇
)
 ,  𝐶 is the free energy of interest, which is 
to be solved in self-consistent manner. 
Comparing Zwanzig and BAR equations, it is notable that ensemble averages for both states 
are needed in BAR method, whereas in Zwanzig equation only that for one is needed. 
Consequently, due to its double-sided sampling, BAR calculation is often more efficient, 
requiring fewer intermediate states to converge.
90
  
  27 
We have also utilised yet another extension of FEP called QM-Non-Boltzmann BAR (QM-
NBB).
91
 The equation introduces QM/MM energies as reweighting terms to the BAR 
equation, such that: 
∆𝐺0→1 = 𝑘𝐵𝑇 ln
(
 
 〈𝑓(𝑈0 − 𝑈1 + 𝐶) exp (
𝑉1
𝑏
𝑘𝐵𝑇
)〉1,𝑏
〈𝑓(𝑈1 − 𝑈0 − 𝐶) exp(
𝑉0
𝑏
𝑘𝐵𝑇
)〉0,𝑏
〈exp (
𝑉0
𝑏
𝑘𝐵𝑇
)〉0,𝑏
〈exp (
𝑉1
𝑏
𝑘𝐵𝑇
)〉1,𝑏
)
 
 
+ 𝐶 
Where the biasing potential 𝑉𝑖
𝑏 (𝑖 = 0, 1)  is the difference between MM and QM/MM 
energies: 
𝑉𝑖
𝑏 = 𝑈𝑖
MM − 𝑈𝑖
QM/MM
 
For alchemical intermediate states, the QM/MM energy is obtained by linear scaling: 
𝑈𝜆
QM/MM
= (1 − 𝜆)𝑈0
QM/MM
+ 𝜆𝑈1
QM/MM
 
QM-NBB has been shown to improve free energy calculations since it includes reweighting 
terms in the form of QM/MM potential, which has higher level of accuracy.
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6.4.2 Potential of mean force  
The potential of mean force (PMF) is the free energy surface along a defined reaction path. 
Since the free energy surface may include high-energy states, conventional MD sampling 
may be inadequate. The common way to adequately sample the energies along a reaction path 
is by performing umbrella sampling, where biasing potentials, typically in harmonic form, are 
used to sample configurations in windows along the reaction path.   
The PMF is then obtained by weighted histogram analysis method (WHAM).
92
 It is a 
maximum likelihood statistical approach that considers the histogram of energy values, 
assign optimal weights, and calculate the best estimate of the unbiased probability 
distribution. The best estimate of the unbiased probability distribution is given by: 
𝑃(𝑥) =
∑ 𝑛𝑖(𝑥)
𝑁
𝑖=1
∑ 𝑀𝑖exp ([𝐴𝑖 − 𝑈bias,𝑖(𝑥)]/𝑘B𝑇)
𝑁
𝑖=1
 
Where N is number of simulations; 𝑖 is simulation index; 𝑛𝑖(𝑥) is number of counts in 
histogram bin associated with 𝑥; 𝑀𝑖 is number of samples of simulation 𝑖; 𝑈bias,𝑖 is biasing 
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potential; 𝐴𝑖 is unknown free energy shift and is solved together with 𝑃(𝑥) by iteration to 
self-consistency: 
𝐴𝑖 = −𝑘B𝑇ln (∑𝑃(𝑥)exp [−
𝑈bias,𝑖(𝑥)
𝑘𝐵𝑇
]
𝑥bins
) 
  
  29 
7 SUMMARY, CONCLUSION, AND OUTLOOK 
7.1 SUMMARY 
 The papers have been arranged according to the computational techniques, from classical 
simulations to ab initio calculations: 
Paper 
Computational 
Technique 
Experimental 
Technique Keyword 
I homology modelling, MD Protein production 
and purification 
Giant virus, protein, 
eRF1 
II MD, λ-dynamics, multiple pH 
regime, force field 
parameterisation 
- nucleic acids, triplex, 
LNA, pK 
III MD, λ-dynamics EMSA Tautomer, nucleic acids, 
triplex, LNA, 
pseudoisocytidine 
IV MD, PMF, QM, BAR/NBB, 
QM/MM 
- Tautomer, ribosome, A-
site, cmo
5
U 
V MD, PPC - Peptide, micelle, 
membrane, adsorption 
Detailed summaries of the papers are presented next, followed by conclusion and future 
outlook. 
I. Megavirales homologues of translation termination factor eRF1: protein 
production, homology modelling, and molecular dynamics  
Giant viruses (Megavirales) are newly discovered group of viruses with large particle and 
genome size, which exceeds some bacteria and archaea.
93
 Intriguingly, their genome 
sequencing reveals that they possess genes homologous to eRF1, which has been shown as 
unlikely to be pseudogenes, since there is evidence of regulation of their expression following 
the viral replication cycle.
94
 
The translation termination factor eRF1 is an important class I factor that recognises the stop 
codon at the end of translation process and mediates peptidyl-tRNA hydrolysis to release the 
translational protein product.
95
 In function, eRF1 may be regarded as tRNA-mimic, since 
codons are typically read by tRNAs. The translation termination process is also assisted by 
class II release factors which may facilitate stop codon reading by class I factor, polypeptide 
release, and ribosome recycling.
96
 
The presence of eRF1 homologues in giant viruses is puzzling. First, viruses typically do not 
encode their own protein translational machinery. Along with eRF1 homologues, sequences 
corresponding to aminoacyl-tRNA synthetases were also found. Second, no sequence 
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homologous to class II release factors was found. Third, the gene contains two internal stop 
codons. To produce a gene product similar in length and sequence to eRF1, the first stop 
codon needs to be readthrough, the second needs +1 codon frameshifting.
97
 Furthermore, this 
is true for many giant viruses, but there is a giant virus whose gene does not have the two 
internal stop codons. However, the presence of internal stop codon itself is not surprising. In 
some bacteria, the gene encoding class I release factor RF2 contains an internal stop codon 
which acts as regulation switch.
98
 
Our initial inquiry was to structurally compare eRF1 and its Megavirales homologues (we 
shall call it vRF1 for brevity). To achieve this, we attempted to produce and purify the 
Megavirales homologues in order to prepare samples for X-ray crystallography and/or NMR 
spectroscopy. We chose E. coli as the protein expression host, cloned the vRF1 genes, and 
subjected them to purification stage. The production and purification of vRF1 were 
challenging mostly due to poor protein yield and solubility. Although we managed to obtain 
sample with good purity, preliminary NMR spectroscopy showed poorly resolved spectrum 
and preliminary crystallographic condition screening did not yield crystal suitable for further 
stage (data not shown in the paper). The experimental investigation was thus paused at this 
stage. 
We then focussed on computational investigation instead. The X-ray crystal structure of 
human eRF1 is available in the PDB. The individual domains are also available as NMR 
structures. We also built vRF1 homology models with eRF1 template with the protein 
structure and function prediction platform, I-TASSER. Notably, the vRF1s do not have a 
small flexible region of eRF1, called the minidomain, that is not fully resolved in the crystal 
structure. In the NMR structure, the minidomain exists in two distinct conformations. 
We then performed molecular dynamics (MD) simulations and compare the dynamics of 
eRF1 and vRF1s. Overall, the secondary structures of eRF1 and vRF1s are conserved in the 
simulation, although there is large interdomain movement. For eRF1, indeed some transient 
and more persistent secondary structures appear in the minidomain region, though the two 
NMR conformations cannot be distinguished.    
II. Modeling pK shift in triplex DNA 
DNA triple helices have been shown to play important roles in cellular processes and have 
been used in many biotechnological and biomedical applications, particularly antigene 
strategy
99
 where the triplex-forming oligonucleotide (TFO) can be used to target intracellular 
duplex DNA.  
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In a parallel triple helix, a homopyrimidine- homopurine duplex is bound by Watson-Crick 
hydrogen bounds, and a third homopyrimidine strand (the TFO) binds to the major groove of 
the duplex via Hoogsteen hydrogen bond to the homopurine strand. Hence, with canonical 
DNA bases, the possible base triads are C
+G–C and  TA–T (‘–’ refers to Watson-Crick and 
‘’ to Hoogsteen base pair), where cytidine in the third strand needs to be protonated to form 
Hoogsteen hydrogen bond.  
Locked nucleic acid (LNA) is a modification that locks the sugar conformation, and is 
typically used to improve triplex formation. In this study, we reparameterised and validated 
the CHARMM force field parameters for LNA (previous parameter: Pande-Nilsson
100
) as 
well as calculated pK values of cytidine in various triplex environment with two different 
approaches, multiple pH regime and λ-dynamics. Multiple pH regime uses MD sampling of 
protonated and deprotonated ensembles, and determine the pK shift by calculating 
electrostatics with linearised Poisson equation.
86
 λ-dynamics incorporates λ, the variable 
which is coupled to the protonation-deprotonation transition, in the dynamics.
84
 
The reparameterised LNA force field reproduced A-form nucleotide geometry and has good 
agreement with experimental structures. The two pK approaches both predict the pK of 
cytidine to be shifted higher than physiological pH in triplex environment. 5-methylation 
shifted pK even higher. Neighbouring LNAs do not seem to have large effect on pK shift. For 
cytidine, multiple pH regime predicts higher pK value than λ-dynamics and similar ones for 
5-methylcytidine. Multiple pH regime predicts downward pK shift when ionic strength is 
increased, while λ-dynamics predicts no change. This is presumably due to the different 
treatments in the long-range interactions in both methods.       
III. Role of Pseudoisocytidine Tautomerization in Triplex-Forming 
Oligonucleotides: In Silico and in Vitro Studies 
In a parallel triple helix, cytidine in the third strand needs to be protonated to form Hoogsteen 
hydrogen bond. Pseudoisocytidine (
Ψ
C) is a cytidine analogue designed to circumvent this 
problem. However, 
Ψ
C exists in two main tautomers, only one of which, 
Ψ
C(H3), is able to 
form Hoogsteen hydrogen bond to form the base triad 
Ψ
C(H3)G–C. 
We have used λ-dynamics84 to model the tautomerisation between the tautomers of ΨC, 
C(H1)⇌Ψ C(H3)Ψ  with various sequence, single-strand, and triplex contexts. We 
complemented the computational prediction with electrophoretic mobility shift assay 
(EMSA), an in vitro binding experiment used to confirm triplex formation. Conventional MD 
simulation was also performed to characterise the structure of triplexes containing 
Ψ
C. 
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As there is no quantitative experimental data on this tautomerisation equilibrium, we assumed 
that the two tautomers exist in equal amount as nucleoside. We calculated the free energy of 
tautomerisation, needed as an input of λ-dynamics, and calibrated the biasing potential force 
needed to efficiently sample the physical end states. We then performed in various single-
stranded trimers and heptamers containing 
Ψ
C. We observed that sequence containing 
consecutive 
Ψ
Cs tend to disfavour 
Ψ
C(H3), while cytidine neighbours tend to favour 
Ψ
C(H3) 
compared to thymine neighbours. LNA does not have clear influence on the tautomerisation. 
In triplex environment, where we have started the simulation starting from the triplex 
structure, 
Ψ
C(H3) fully dominates, even when 
Ψ
C is consecutive.  
EMSA shows that sequences containing three or more consecutive 
Ψ
C do not form triplex 
under intranuclear conditions at pH 7.4, even when intercalators that promote triplex 
formation were used. On the other hand, when we have another sequence containing non-
consecutive 
Ψ
C and LNA, it shows triplex formation. We modelled the latter triplex with 
conventional MD simulation and characterise the triplex structure and found that its duplex in 
triplex conformation is consistent with what has been previously observed,
6
 that duplex in 
triplex conformation has slide and twist values of A-type geometry with x-displacement value 
between A- and B-types.        
IV. Keto-enol tautomerisation of modified uridine in ribosome decoding 
centre 
An unexpected Watson-Crick geometry was observed for a modified U:G base pair in the 
ribosome decoding centre at third codon position, where wobble geometry is expected 
instead.
101
 With this modification of U on the tRNA, 5-oxyacetic acid, it can accept all four 
bases on the mRNA.
12
 The authors of the X-ray crystallographic study speculated that the U 
enol tautomer, much rarer than the keto tautomer, is consistent with the observed Watson-
Crick geometry. However, since at this resolution hydrogen atoms are not resolved, this 
remains an open question.   
We have employed ab initio calculations to calculate the energy of the tautomers alone and in 
basepair with polarisable continuum model (PCM)
66
 to account for solvent effects. We have 
found that the modification offers very little stabilisation to the enol tautomer, alone and in 
Watson-Crick basepair geometry. There is significant stabilisation if we allow the enol 
hydroxyl to form intramolecular hydrogen bond with the acetic acid group in the 
modification, but this geometry would not be consistent with the X-ray structure. 
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To account for the ribosomal environment, we performed MD simulation and free energy 
calculation with the ribosomal context. We have taken a spherical region of the decoding 
centre and used deformable stochastic boundary potential
77-78
 to contain the system. For the 
free energy calculation, we have utilised Bennett acceptance ratio (BAR)
89
 as well as 
quantum mechanics-non Boltzmann BAR (QM-NBB)
91
 which involves reweighting factors 
from QM/MM calculation for greater accuracy. Free energy calculation shows that the 
ribosomal environment does not offer significant stabilisation of the enol tautomer compared 
to the aqueous environment.  
MD simulation cannot maintain the geometry observed in the X-ray structure fully. First, a 
geometry close to Watson-Crick was achieved, but with only two hydrogen bonds maintained 
and the U enol hydrogen points away from the basepair partner G and does not form a 
hydrogen bond. Second, the modification moiety points away from the Watson-Crick edge, 
while it points towards the Watson-Crick edge in the X-ray structure.  
We calculated the PMF along the dihedral that describes to the enol hydrogen rotation and 
found that the orientation observed in the MD simulation was stabilised in aqueous 
environment by water-bridged intramolecular hydrogen bond. Since the orientation 
modification moiety in the X-ray structure cannot be maintained in MD simulation, we also 
propose that there may be entities not resolved by X-ray diffraction that stabilise this 
orientation, such as Mg
2+
, for which we performed preliminary MD simulation.  
We also revisited our initial assumptions such as the protonation state of the acetic acid in the 
modification moiety that we assumed to be protonated, as well as the possibility of N3-
deprotonated uridine. For the latter, we performed preliminary MD simulation but still did not 
achieve Watson-Crick geometry.     
V. Adsorption and folding dynamics of MPER of HIV‐1 gp41 in the 
presence of DPC micelle  
Membrane-proximal ectodomain region (MPER) of HIV-1 is part of its envelope 
glycoprotein gp41, which undergoes conformational change to facilitate the viral membrane 
fusion.
1-2
 This region has been known to be epitope of several monoclonal antibodies
102-104
 
and due to its proximity to the membrane, it has different structural features compared to a 
typical soluble protein.  
Protein-polarised charge (PPC)
69
 scheme is a charge updating scheme based on iteration of 
quantum mechanical calculation at B3LYP/6-31G* and Poisson-Boltzmann linearised 
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equation to implicitly include polarisation by updating charges in response to the 
environment. 
In this study, we simulated MPER peptide with starting charges from both AMBER03 force 
field and PPC, in the absence and presence of dodecylphosphatidylcholine (DPC) micelle. 
The starting structure is taken from NMR study.
105
 Without DPC micelle, the MPER peptide 
is not structurally preserved well with PPC preserve it slightly better compared to with 
AMBER charges. In the presence of micelle, MPER peptide always adsorb to the micelle, 
with PPC preserving the peptide structure better.  
We also attempted de novo folding of MPER peptide from its linear structure with adaptive 
hydrogen bond charge (AHBC)
70
 charge updating scheme which is a PPC variant, but the 
charge update is only applied to residues involved in hydrogen bonding. Unlike the one-time 
PPC update above, AHBC is applied by locating hydrogen bonds every 5 ps. The peptide 
folded similar to the NMR structure while undergoing adsorption to the micelle. The peptide 
adsorption to the micelle appears to aid the folding process.       
7.2 CONCLUSION AND OUTLOOK 
In Paper I, we gained some insights in the structure of vRF1s, and the missing minidomain 
region may be a crucial structural feature. However, there is the caveat that these structures 
are homology models and the validation from experimental investigations still awaits. X-ray 
crystallography would probably the most suitable experimental technique to resolve their 
three-dimensional structures. The minidomain region itself would probably benefit from a 
more careful loop modelling, which we did attempt, but with no conclusive result. 
In Paper II, we updated the LNA force field parameters and predicted pK values for cytidine 
in triplex environment. Since experimental pK values of cytidine in triplexes are sparse, 
computational predictions would be useful in the context of designing a cytidine-containing 
TFO for antigene therapy. Multiple pH regime with explicit ions was shown to offer good 
predictions, so future investigations involving nucleic acids may take note. λ-dynamics also 
offers predictions where some are close to the experimental value, but it has greater 
computational cost. pK calculations may be used in other systems that would benefit from 
such predictions where experimental measurement may be difficult or costly.  
In Paper III, we employed λ-dynamics to complement in vitro binding experimental result. 
This study illustrates how computational methods can provide insights to processes which are 
experimentally more intractable. It would be interesting to apply similar strategy to other 
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tautomeric systems. What we have known so far about pseudoisocytidine and its 
tautomerisation may inform applications other than cytidine substitution in TFO.  
In Paper IV, we explored the possibility of U enol tautomer forming Watson-Crick basepair 
with G in the ribosomal decoding centre at the third position. We conclude that the energetics 
and what we have observed in MD simulation is not consistent with the U enol tautomer. We 
have offered several alternative hypotheses which can be further explored in the future: the 
inclusion of Mg
2+
, the protonation state of the oxyacetic acid moiety, the N3-deprotonated 
form of uridine, and the possibility of enol tautomer of guanine instead of uridine. More 
experimental data such as higher resolution structure may also be needed. 
In Paper V, we did various simulations of a peptide associated with a micelle. The 
electrostatics proves to be crucial, since the method with more extensive electrostatics 
description is able to structurally preserve or fold the peptide better. However, since the 
charge update scheme is computationally costly, it has not gained much widespread use. In 
the future, we may focus on reducing the computational cost or devising other schemes. 
MPER peptide is also only a small subset of the membrane fusion machinery. Other parts of 
the machinery and itself as a whole also need to be investigated in order to understand the 
membrane fusion mechanism better.  
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8 POPULAR SCIENCE SUMMARY 
While the mechanical engineer looks at a machine and dismantle its innards to understand its 
workings, in the same way the structural biologist looks at life and subjects its inner 
clockwork to scrutiny. But the latter faces a fundamental problem: these engines are 
extremely tiny and frustratingly so – this is a challenge beyond van Leeuwenhoek's 
microscopes: no light microscope can resolve the structure of the protein molecule, for it is 
optically impossible; the visible light wavelength is 400-700 nm, while the ribosome, itself a 
complex of many pieces of proteins and nucleic acids, is 20-30 nm in dimension.  
However, we have biophysical tools to tease out the secrets of nature's architecture, among 
them are X-ray crystallography, NMR spectroscopy, and cryo-electron microscopy – all of 
them can produce 3D representations of molecules, and then some. These 3D coordinates are 
commonly deposited in a public depository called the Protein Data Bank.  
It is worth pointing out that the construction of these models is not the same way that one 
typically thinks about resolving images – think of a camera: shine a light on the object, 
capture the light reflections, done – only electron microscopy, among the three, works like 
this. Even then, an assemblage of these images is taken to construct the final model. X-ray 
crystallography is superficially similar, initially: shine an X-ray on a crystal, but what is 
captured then is diffraction patterns (recall Rosalind Franklin's famous diffraction pattern of 
the DNA double helix) and calculations have to be made to process the patterns to reconstruct 
the model. NMR spectroscopy too begins with shining radiowaves on the sample, but what it 
records is the magnetic properties of atomic nuclei, which can be used to find out distances 
between atoms – these distances are inputted to the model building, which restrains the 
conformation narrowly to the final model.      
If we step back from model building, which is sample measurement, there is sample 
preparation, a messy backstage work that is often unseen. In the case of proteins, a common 
production strategy is to genetically modify bacteria, typically E. coli, to coax them to 
produce the desired protein, as the author has done in Paper I. Proteins function in very 
diverse environments – aqueous to lipidous, low to high pH, dilute to concentrated – yet our 
production techniques greatly favour the soluble protein. NMR is still largely done in 
solution; crystallography requires highly solubilised protein in order to grow good crystals; 
cryo-EM specimen is also prepared in aqua, though at less forgiving concentration than 
crystallography. 
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Aren't these only models, then? — is a question the structural biologist sooner or later 
encounters. Yes and no. On one hand, it is true there are limitations such as missing parts not 
resolved by X-ray crystallography. But on the other hand, to wax philosophical, everything is 
a model. This text you are reading on the screen or the paper is your brain's mental construct 
– to be sure, everything: the text, the screen, the paper, your hands. The molecular modeller 
indeed should know the inherent limitations of the models, but it does not mean that they 
render the model useless. 
What a computational biophysicist often does is to extract more information from these static 
models. X-ray and cryo-EM structures are often one single 'frame' while an NMR structure 
might include some 20 different conformations. An X-ray structure often does not resolve 
hydrogens since they do not have much electron to diffract. Paper IV opens with exactly this 
problem: the common placing of hydrogen in an X-ray structure does not make sense; could 
it be that the hydrogen is placed on a different site? Calculations were then performed to see 
whether there is space for this hydrogen, whether there is enough energy, and so on. 
Molecular dynamics, the computational technique that is a prominent theme of this thesis, 
incorporates the classical mechanics, treating the biomolecules like solid charged balls having 
different attractions and repulsions, connected with springs of different lengths and rigidities, 
moving under Newton's law of motion. This is not the most accurate description, as quantum 
mechanics would be it, but since the latter requires heavy computation, so it is used sparingly, 
or compromisingly with approximations, or in hybrid conjunction with the classical 
mechanics description. The parameters that go to the molecular model used for molecular 
dynamics are obtained from real-world measurements and high-level quantum mechanical 
calculation, and then carefully calibrated and validated, so that they would correctly 
reproduce biophysical properties.  
Paper I provide examples of conventional molecular dynamics simulations, wherein a protein 
is put amidst water molecules and ions, then simulated. In Paper I, the interest is in the 
dynamics of the protein, especially since the 'arms' of the T-shaped protein is known to move 
a lot. Proteins with similar sequence, said to be homologous, were also structurally predicted 
and simulated to compare their structures, especially since the homologues are missing a 
certain region of the template protein. 
One limitation of the conventional molecular dynamics is that it cannot take into account 
chemical reactions, which involves bond breaking – for the models are solid balls and springs 
with fixed rigidities. Lambda-dynamics, used in Papers II and III, is an extension of the 
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technique that addresses exactly this issue, where the eponymous 'lambda' is a variable that 
accounts for the transition of interest. The chemical transitions of interest in this thesis are 
acid-base protonation (Paper II) and tautomerisation (Paper III). The added variable adds to 
the computation: the parameters of both states are needed, the free energy between the two 
states has to be calculated, and sampling has to be tuned in order for it not to linger at 
intermediate states, which are not of interest. 
In Paper II, lambda-dynamics allows calculation of pKa, the acid dissociation constant, which 
is a measure of how strong an acid is. In this case, our interest is one of nucleic acid bases, C; 
how its pKa changes when put in different environments, for in the environment of interest, 
triplex nucleic acids, experimental measurement is a challenge.  
In Paper III, lambda-dynamics was used to model transition between two tautomers of a 
nucleic acid base – tautomers are closely related isomers where they only differ by the 
position of one hydrogen atom. Here we have experimental data of triplex nucleic acid 
binding which was initially puzzling, but in the light of the tautomerisation data from the 
simulations, was better explained. 
Paper IV is concerned also with tautomers, but that of the nucleic acid base U. As mentioned 
above, the common tautomer does not fit into the model and the other, much rarer tautomer, 
seems to. The environment is the ribosome, which might be special and somehow 
compensates the energy cost. We employed ab initio quantum mechanical calculations, free 
energy calculations, hybrid QM/MM calculations, and molecular dynamics simulation to 
determine whether this is so. 
In Paper V, a ball of lipid molecules called a micelle is also introduced to the system to study 
how the protein would interact with it. The protein in question is in fact part of HIV infection 
machinery. Understanding it better will help to devise strategies against the virus. Hybrid 
method that incorporates quantum mechanical calculations to the molecular dynamics 
simulation was also used to better describe the electrostatics of the solvated peptide. 
The structural biologist stares at life and tries to decode its molecular machinery. This thesis 
is concerned with just a small set of her repertoire of tools, the computational techniques. She 
keeps tinkering; she keeps wondering; for "What is life?" is not all a trivial question.  
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